mepolizumab

Details

Generic Name:
mepolizumab
Project Status:
Not filed
Therapeutic Area:
Eosinophilic granulomatosis with polyangiitis
Manufacturer:
GlaxoSmithKline Inc.
Brand Name:
Nucala
Project Line:
Reimbursement Review
Project Number:
N/A
Submission Type:
Non Submission
Indications:
As an add-on to corticosteroids for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis.
Recommendation Type:
CADTH is unable to recommend reimbursement as a submission was not filed by the manufacturer